Outpatient follow-up of patients with bronchiectasis by a primary care physician. Guidelines

Follow-up of patients with bronchiectasis at various age stages shows that even with a favorable course of the disease, clinical improvement, lung morphological abnormalities do not regress, are the basis for exacerbations and chronicity of bronchopulmonary inflammation. Outpatient follow-up is the main approach to the prevention and early diagnosis of exacerbations, complications and progression of the disease, and the implementation of medical rehabilitation. The guidelines contain a description of the algorithm for appointment of bronchiectasis patients by a general practitioner and supporting materials. The guidelines are intended for general practitioners (family doctors), as well as for mid-level health providers working with the above-mentioned doctors, for paramedics performing the doctor functions, pulmonologists and other medical specialists involved in the management of patients with bronchiectasis, for heads of primary health care facilities.

1. Avdeev SN, Kondratieva EI, Kozlov RS, et al. Bronchiectasis: a review of the literature in the preparation of clinical recommendations for 2024. Pulmonology. 2024;34(2):158-74. (In Russ.) doi:10.18093/0869-0189-2024-342-158-174.

2. Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629. doi:10.1183/13993003.00629-2017.

3. Zarembo IA, Kiseleva EA, Zarayskaya LS, et al. Bronchiectasis: a modern view of the problem. Practical pulmonology. 2015;4:27-33. (In Russ.) EDN VRCTKZ.

4. Anaev EH. Modern approaches to the management of patients with bronchiectasis. Pulmonology. 2020;30(1):81-91. (In Russ.) doi:10.18093/0869-0189-2019-29-4-468-476.

5. Avdeev SN, Chuchalin AG, Abrosimov VN. Respiratory medicine. The manual in 3 vols. 2nd ed., reprint. and an additional one. Russian Respiratory Society; edited by Academician of the Russian Academy of Sciences A. G. Chuchalin. Moscow: Litterra, 2017. (In Russ.)

6. Chuchalin AG. Bronchiectasis. Terapevticheskii Arkhiv. 2017;89(3):4-17. (In Russ.) Чучалин А. Г. Бронхоэктазы. Терапевтический архив. 2017;89(3):4-17. doi:10.17116/ terarkh20178934-17.

7. Smirnova MI, Samorodskaya IV, Drapkina OM. Variability of mortality rates from respiratory diseases in the regions of the Russian Federation during the COVID-19 pandemic and the three previous years. Preventive medicine. 2024;27(4):82-8. (In Russ.) doi:10.17116/ profmed20242704182.

8. Drapkina OM. Kontsevaya AV, Kalinina AM, et al. Prevention of chronic noncommunicable diseases in the Russian Federation. National Guidelines 2022. Cardiovascular therapy and prevention. 2022;21(4):3235. (In Russ.) doi:10.15829/1728-8800-2022-3235.

9. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Comorbidity of patients with chronic non-communicable diseases in the practice of a general practitioner. The Eurasian leadership. Cardiovascular therapy and prevention. 2024;23(3):3696. (In Russ.) doi:10.15829/1728-8800-2024-3996. EDN: AVZLPJ.

10. Hill AT, Sullivan AL, Chalmers JD, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax 2019;74 (Suppl 1):1-69. doi:10.1136/ thoraxjnl-2018-212463.

11. Gorbunov VM, Smirnova MI, Kuryokhyan AS, Drapkina OM. Assessment of clinical and outpatient blood pressure in the practical work of a primary care physician. Methodological recommendations. Cardiovascular therapy and prevention. 2023;22(7):3666. (In Russ.) doi:10.15829/1728-8800-2023-3666. EDN YRHRNI.

12. Boytsov SA, Pogosova NV, Ansheles AA, et al. Cardiovascular prevention 2022. Russian national recommendations. Russian Journal of Cardiology. 2023;28(5):5452. (In Russ.) doi:10.15829/1560-4071-2023-5452. EDN EUDWYG.

13. Diagnosis and treatment of chronic pulmonary aspergillosis: clinical guidelines of the European Respiratory Society and the European Society of Clinical Microbiology and Infectious Diseases. Pulmonology. 2016;26(6):657-80. (In Russ.) doi:10.18093/0869-0189-2016-26-6-657-679. EDN VNIQDC.

14. Milacic N, Milacic B, Dunjic О, et al. Validity of CAT and mMRC — dyspnea score in evaluation of COPD severity. Acta Medica Medianae. 2015;54(1):66-9. doi:10.5633/amm.2015.0111.

15. Drapkina OM, Briko NI, Kostinov MP, et al. Immunization of adults. Methodological recommendations. M., Federal State Budgetary Institution "NMIC TPM" of the Ministry of Health of the Russian Federation. 2020; 248 p. (In Russ.) ISBN: 978-5-6043991-3-2.

16. Avdeev SN, Alieva MH, Baranov AA, et al. Vaccination of pneumococcal infection in children and adults. Methodological recommendations. Preventive medicine. 2023;26(92):323. (In Russ.) doi:10.17116/profmed2023260923.

17. Ridda I, Yin JK, King C, et al. The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. Vaccine. 2012;30(48):674552. doi:10.1016/j.vaccine.2012.08.079.

18. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) doi:10.15829/1560-4071-2020-3-3786.

19. Holland AE, Spruit MA, Troosters T. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-46. doi:10.1183/ 09031936.00150314.

20. Borg GAV. Psycho-physical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377-381.